期刊
JOURNAL OF INTERNAL MEDICINE
卷 272, 期 3, 页码 201-223出版社
WILEY
DOI: 10.1111/j.1365-2796.2012.02574.x
关键词
experimental; hepatology; liver; surgery; transplantation immunology; a-1-antitrypsin deficiency
资金
- Research Strategy Committee Karolinska Institute
- Stockholm County Council (Forskar ST)
- Stockholm County Council
- Karolinska Institutet
Inherited metabolic diseases of the liver are characterized by deficiency of a hepatic enzyme or protein often resulting in life-threatening disease. The remaining liver function is usually normal. For most patients, treatment consists of supportive therapy, and the only curative option is liver transplantation. Hepatocyte transplantation is a promising therapy for patients with inherited metabolic liver diseases, which offers a less invasive and fully reversible approach. Procedure-related complications are rare. Here, we review the experience of hepatocyte transplantation for metabolic liver diseases and discuss the major obstacles that need to be overcome to establish hepatocyte transplantation as a reliable treatment option in the clinic.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据